Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Inceptor Bio a biotechnology company advancing cell therapies for difficulttotreat cancers today announced a collaboration with University of Minnesota The aim of this collaboration is to build a novel induced pluripotent stem cells iPSC platform tha...
Akebia Therapeutics Inc a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease today announced that it has executed an agreement to terminate the US and exUS vadadustat Collaboration and License Agreemen...
Nurix Therapeutics Inc a clinical stage biopharmaceutical company developing targeted protein modulation drugs today announced that it has received clearance from the US Food and Drug Administration FDA for the companys Investigational New Drug IND a...
Ocuphire Pharma Inc a clinicalstage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders today announced that the United States Patent and Trademark Office...
Regeneron Pharmaceuticals Inc announced the US Food and Drug Administration FDA has accepted for review the EYLEA aflibercept Injection supplemental Biologics License Application sBLA for an every week mg dosing regimen after initial monthly doses i...
Apnimed a clinicalstage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea OSA and related disorders announced today that the US Food and Drug Administration FDA has granted Fast Track design...
Evofem Biosciences Inc today announced it has reached an agreement with one of the nations largest pharmacy benefit managers PBMs to ensure most women covered by this plan can fill their Phexxi lactic acid citric acid potassium bitartrate prescriptio...
Beyond Air Inc a clinicalstage medical device and biopharmaceutical company focused on developing inhaled nitric oxide NO for the treatment of patients with respiratory conditions including serious lung infections and pulmonary hypertension and throu...
ProPhase Labs Inc a diversified diagnostics and genomics company today announced the formation of whollyowned subsidiary ProPhase BioPharma Inc PBIO for the licensing and development of novel drugs compounds and biotechnology PBIO will focus on advan...
With the realization of the first successful customer fills Vetter a leading global Contract Development and Manufacturing Organization CDMO has reached another milestone at its new clinical manufacturing facility in Rankweil Austria Further batches...
